DANIEL WATSON: Open Payments
NPI 1730687476 · ELKIN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 10 payments from 8 companies in 2025. Trend: 2023 $1,024 · 2024 $445 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $51 |
| Lilly USA, LLC | 1 | $42 |
| PFIZER INC. | 2 | $36 |
| Globus Medical, Inc. | 1 | $26 |
| SCILEX PHARMACEUTICALS INC. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: ZEPBOUND, NURTEC ODT, Senza, ZTLido, Belbuca, TRELEGY ELLIPTA, CAPLYTA.
Industry payments across NC — which companies pay providers there.
